Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nipoka is a German biotechnology company specializing in advanced imaging solutions and automated analysis for renal research and diagnostics. A spin-off from the University of Greifswald, the company provides proprietary technology to quantify podocyte health and glomerular filtration barrier integrity. Their core product, PodoCount, utilizes high-resolution microscopy and specialized algorithms to offer precise biomarkers for kidney disease progression. Nipoka's services are primarily used by pharmaceutical companies and academic researchers to evaluate drug efficacy and disease mechanisms in nephrology. The company's approach transforms traditional pathology into a quantitative digital science.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nipoka.